There’s No Need To Panic Or Freeze When It Comes To Lexicon Pharmaceuticals Inc (NASDAQ: LXRX)

After Hours

The risks associated with pre-market and after-hours trading may be slightly higher than the regular market hours. The reason is that extended-hours trading may result in wider spreads for particular security due to lower liquidity and higher volatility as issuers often announce critical financial information outside regular trading hours. The stock was recently discussed on Yahoo Finance as it revealed that Lexicon Pharmaceuticals to Participate in the 23rd Annual Needham Virtual Healthcare Conference.

Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.

Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!

Get the FREE Report with all the details here.


Sponsored

Stocks Info

The company is listed on the NASDAQ and operates within the Biotechnology industry segment. The current market capitalization of Lexicon Pharmaceuticals Inc is $502.33M. A total of 4.38 million shares were traded on the day, compared to an average of 4.81M shares.

In the most recent transaction, COATS LONNEL bought 90,000 shares of LXRX for 1.05 per share on Nov 16 ’23. After the transaction, the Chief Executive Officer now owns 914,359 company shares. In a previous transaction on Nov 10 ’23, COATS LONNEL bought 10,000 shares at 1.01 per share. LXRX shares that Chief Executive Officer owns now total 824,359.

Among the insiders who bought shares, DEBBANE RAYMOND acquired of 148,820 shares on Oct 12 ’23 at a per-share price of $1.03. This resulted in the Director holding 1,340,847 shares of LXRX after the transaction. In another insider transaction, DEBBANE RAYMOND bought 342,874 shares at $1.08 per share on Oct 11 ’23. Company shares held by the Director now total 1,192,027.

It has been observed that price targets are rarely accurate, but they can exert some influence from time to time, and are often accepted as valuable in the market. In terms of 52-week highs and lows, LXRX has a high of $3.79 and a low of $0.92.

As of this writing, LXRX has an earnings estimate of -$0.2 per share for the current quarter. EPS was calculated based on a consensus of 3 estimates, with a high estimate of -$0.19 per share and a lower estimate of -$0.2.

Balance Sheet Annually/Quarterly

An equity investor’s investment can be viewed on a balance sheet by looking at what assets and liabilities the company has. Investors can determine the company’s prospects by calculating its financial ratios based on this information. LXRX’s latest balance sheet shows that the firm has $86.74M in Cash & Short Term Investments as of fiscal 2021. There were $2.28M in debt and $22.12M in liabilities at the time. Its Book Value Per Share was $0.38, while its Total Shareholder’s Equity was $113.59M.

Analysts Opinion

There may be slightly higher risks associated with pre-market and after-hours trading than during regular market hours. Due to the fact that issuers often announce critical financial information outside of regular trading hours, extended-hours trading may result in wider spreads for particular securities. Currently, 0 analysts are providing their opinions on the stock. On a scale of 1 to 5, with 1 being Sell and 5 being Buy, the average analyst rating for LXRX is Buy with a score of 4.00.

Most Popular

Related Posts